Benign Prostate Obstruction (BPO)
10
4
4
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (10)
Oxiblume:CoQ10 (Ralivia) Therapy for Benign Prostatic Hyperplasia:
Effect of Catheter Duration on Prostate Laser Enucleation Surgery Outcomes in Patients With Urinary Retention
Enucleation Ratio as a Novel Predictor of Symptomatic Improvement After HoLEP
SteamOne - Prospective Database for Rezum Water Vapor Therapy of the Prostate
Outcome and Patient Experiences After Transurethral Resection and Bipolar Enucleation of the Prostate - a Multi-center, Randomized Controlled Trial.
The Impact of Age and Sex on Anticipated and Experienced Pain in First-Time Outpatient Flexible Cystoscopy
The Effects of Holmium Laser Enucleation and Thulium Laser Enucleation on Continence, Urethral Stricture, and Sexual Function in Benign Prostatic Hyperplasia
Association Between Qmax/eGFR Ratio and LUTS Severity in Men Over 40
Uroflowmetry and IPSS Factors Influencing Surgical Decision
Clinical Outcomes and Ejaculatory Function in BPO Patients Treated With Silodosin